EUA is still very much on the table for Moderate. This is

New Post Public Reply Private Reply Replies (1) Message Board
JLang skezan #56282
577
EUA is still very much on the table for Moderate. This is perfectly in line with the PII results... not much signal was seen with patients below a baseline 4 on the clinical scale. "Approval" means all the studies are wrapped up, CytoDyn submits the request, they get scheduled a PDUFA date, six months later etc etc etc.

With the criteria established that just Moderate, > 4 clinical are being examined, with NEWS2, viremia, and a host of Cytokine markers are the endpoints, along with clinical improvement, any indication of effecacy in a Moderate PIII trial will justify EUA for that population. Neither the US nor UK would overlook that.

2. Jury is out... depends on how clear the interim results are. Sounds like the UK is considering it.

3-6: check

7: ....

8: not if it doesn't pass

S/C is the next catalyst. Another Buying Opp.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

ValidiFI Teams with Velera to Enhance Credit Union Services

Updated Category News Views 182

ValidiFI Partners with Velera to Enhance Credit Union Services ValidiFI, a recognized leader in bank account validation and payment intelligence, has joined forces with Velera, a prominent credit union service organization (CUSO). This partnership aims to provide cutting-edge financial solutions to credit unions, enhancing their member onboarding and application processes...

Continue Reading
Join the Movement: Ending Youth Homelessness This November

Updated Category News Views 168

Covenant House Urges Action: Youth Homelessness Awareness Month This November, Covenant House calls upon individuals, community advocates, business leaders, and influencers to unite and take significant actions to combat youth homelessness. As the largest nonprofit organization operating in 34 cities throughout five countries, Covenant House is dedicated to providing safe...

Continue Reading
Shilpa Pharma Lifesciences Earns EcoVadis Gold Medal for Sustainability

Updated Category News Views 142

Shilpa Pharma Lifesciences Recognized with EcoVadis Gold Medal Shilpa Pharma Lifesciences Limited has recently achieved a remarkable milestone by receiving the esteemed EcoVadis Gold Medal, awarded by the world's most recognized provider of sustainability ratings. This accolade emphasizes the dedication of the company towards sustainable practices that are vital in...

Continue Reading
Concerns for Gen Xers: Retirement Readiness Lags Behind Needs

Updated Category News Views 121

Gen X Faces Retirement Challenges As the oldest members of Generation X near the age of 60, a concerning trend is emerging regarding their financial preparedness for retirement. A recent study indicated that only a mere 14% of Americans aged 44 to 59 feel they have adequately saved for retirement. This demographic, now entering a vital stage of their lives, expresses a...

Continue Reading
Target Corporation Holiday Sales Insights and Leadership Changes

Updated Category News Views 244

Target Corporation Reports Holiday Sales Performance Target Corporation (NYSE: TGT) has announced some exciting news regarding its holiday sales performance during the combined months of November and December. The company reported a total sales increase of 2.8 percent compared to the previous year, with comparable sales increasing by 2 percent. Additionally, digital sales...

Continue Reading